Opportunities in Proton Therapy 2007

Ultima Vez Modificado: 4 de junio del 2007

Podcast of The "Opportunities in Proton Therapy" symposium from November 7, 2006. Worldwide cancer experts give you a unique opportunity to discover and share the information on the latest developments in Proton Therapy including dose distribution comparisons and anticipated gains, detailed clinical applications and trends in Proton Therapy care. Experience the collected knowledge of Nancy Mendenhall, MD and Tom DeLaney, MD as well as a host of other thought leaders in the exciting field of Proton Therapy.

Subscribe to OncoLink Podcasts

iTunes Manual Instructions:

1. Click Advanced
2. Subscribe to Podcast
3. Add URL http://tv.oncolink.org/Podcasts/podcasts.xml

Also available as an on-demand webcast:
OncoLink TV: Opportunities in Proton Therapy

You may also use Quicktime to view the individual presentations.

Welcome and Introduction
Nancy Price Mendenhall, M.D., Professor, Associate Chair, and Medical Director, University of Florida Proton Therapy Institute, Jacksonville, FL

Rationale for Proton Therapy
Thomas F. DeLaney, M.D., Associate Professor of Radiation Oncology, Massachusetts General Hospital, Francis H. Burr Proton Therapy Center, Boston, MA

Eye
Bertil Damato, M.D., Hon. Professor of Ophthalmology, University of Liverpool, Ocular Oncology Service, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool UK

Chordoma/Chondrosarcoma
Norbert J. Liebsch, M.D., Ph.D., Assistant Professor of Radiation Oncology, Massachusetts General Hospital Cancer Center, Boston, MA

Craniopharyngioma
Claire Alapetite, M.D, Ph.D., Institut Curie, Radiation Oncology Department, Paris, and Institut Curie Centre de Protonthérapie d'Orsay, France

Medulloblastoma
Nancy J. Tarbell, M.D., Professor of Radiation Oncology, and Director, Pediatric Radiation Oncology, Massachusetts General Hospital Cancer Center, Boston, MA

Head and Neck
Robert Malyapa, M.D., Assistant Professor, Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL

Liver – Yasuyuki Akine, M.D., Professor, Graduate School of Comprehensive Human Sciences (Radiation Oncology) and Director, Proton Medical Research Center Director, Department of Radiation Oncology, University Hospital University of Tsukuba, Japan

Lung
Takashi Ogino, M.D., National Cancer Center Hospital East, Kashiwa, Chiba, Japan

Esophagus
Yasuyuki Akine, M.D.

Pelvic Sarcoma
Gudrun Goitein, M.D., Head Division of Radiation Medicine, Paul Scherrer Institut, CH
5232 Villigen PSI, Switzerland

Prostate
Carl J. Rossi, Jr., M.D., Loma Linda University Medical Center, Department of Radiation Medicine, Loma Linda, CA

Prostate (with Carbon)
Hiroshi Tsuji, M.D., Research Center for Charged Particle Therapy, National Institute of Radiology Sciences, Univ of Tsukuba, Japan

Abdominal Lymphoma
Allan F. Thornton, M.D., Midwest Proton Therapy Center, Bloomington, IN

Proton Therapy Pitfalls
Roundtable Discussion with Carl J. Rossi, Jr., M.D.,. Loma Linda University Medical Center, Department of Radiation Medicine, Loma Linda, CA; Thomas DeLaney, M.D.; and Gudrun Goitein, M.D.

Special Physics Issues
Thomas Bortfeld, Ph. D., Associate Professor of Radiation Oncology, Director of Physics Research, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA

Special Physics Issues
Jatinder R. Palta, Ph.D., University of Florida Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL

Financial Issues
C. Craig Tisher, M.D., Dean, College of Medicine, University of Florida, Gainesville, FL